If you have any questions, consult a healthcare professional for guidance tailored to your needs
PTAB institution rates for pharmaceutical patents ran at approximately 60-65% historically, and claim cancellation rates at instituted trials ran above 70%, though these figures have moderated somewhat under more recent USPTO director guidance
Circulation 120 , 16401645 (2009)
Your doctor will consider several factors, including: The reason for stopping (side effects, cost, treatment goals achieved, or switching to alternative therapy) Your current glycaemic control and HbA1c levels Other diabetes medications you are taking Your overall cardiovascular risk profile Plans for alternative glucose management strategies If you are taking insulin or sulfonylureas alongside Trulicity, your doctor may need to adjust these doses when Trulicity is stopped to reduce the risk of hyperglycaemia while avoiding hypoglycaemia
Any additional urinary effects would come from tirzepatide typically producing greater weight loss, which means slightly more glycogen depletion and water release